Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Fortress Biotech, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

  Security
 Type 		Security
Class
Title		 Fee
Calculation
 or Carry
 Forward
 Rule 		Amount
Registered 		Proposed
 Maximum
Offering
Price Per
Share 		Maximum
 Aggregate
Offering
Price 		Fee
Rate		 Amount of
Registration
Fee
Carry Forward Securities
Fees Previously     Paid   Equity Common
Stock,
no par
value per share		 457(c) 2,103,887(1) (2) (2) (2)  (2) 
Fees Previously     Paid Equity Common
Stock,
no par
value per share		 457(o) 9,188,305(3) (4) (4) (4) (4)
   Total Offering Amounts         $3,504.79
   Total Fees Previously Paid         $3,504.79
   Total Fee Offsets         $0.00 
   Net Fees Due         $0.00 

 

(1) Represents the sum of up to 2,103,887 shares of Common Stock (i) issuable upon exercise of outstanding warrants and (ii) issued under a dividend and exchange agreement between the registrant and a controlled subsidiary and pursuant to the terms of the corresponding preferred stock.

 

(2) This registration statement registers 2,103,887 shares of Common Stock. These shares were registered on the following registration statements:
   
  · A registration statement on Form S-3 originally filed with the Securities and Exchange Commission (“SEC”) on June 20, 2024, File No. 333-280342, at which time a filing fee of $653.04, computed in accordance with Rule 457(c) under the Securities Act, was paid;
     
  · A registration statement on Form S-3 originally filed with the SEC on February 10, 2023, File No. 333-269687, at which time a filing fee of $53.55, computed in accordance with Rule 457(c) under the Securities Act, was paid; and
     
  · A registration statement on Form S-3 originally filed with the SEC on November 9, 2020, File No. 333-249983, at which time a filing fee of $549.86, computed in accordance with Rule 457(c) under the Securities Act, was paid.

 

(3) Represents the sum of up to 9,188,305 shares of Common Stock issuable upon exercise of outstanding warrants that were publicly sold.

 

(4) This registration statement registers 9,188,305 shares of Common Stock. These shares were initially registered on a registration statement on Form S-3 originally filed with the SEC on November 10, 2023, File No. 333-258145 registering up to $125,000,000 in aggregate principal amount of common stock, preferred stock, warrants, debt securities, and units, at which time a filing fee of $13,637.50, computed in accordance with Rule 457(o) under the Securities Act, was paid. Of which that filing fee amount, $2,248.34 related to the 9,188,305 offered by Fortress Biotech, Inc.